Natural Health Trends Corp. NHTC
0.90
(0.11)
(10.89%)
as of 25 Sep
- Market cap
- $8.7M
- P/E
- 0.0×
Follow NHTC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.26 | 0.89 | 0.74 | 0.42 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
454.91 | (37.04) | (35.51) | (11.13) | |
P/B ratio |
1.97 | 1.52 | 1.72 | 1.00 | |
Price to Tangible BV |
2.11 | 1.64 | 1.93 | 1.13 | |
EV/Sales |
0.47 | 0.17 | 0.18 | (0.10) | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 1.59 | |
EV/Operating CF |
(3.92) | (1.11) | (0.97) | 1.14 | |
EV/FCF |
(3.85) | (1.10) | (0.95) | 0.98 | |
Quick Ratio |
2.17 | 2.11 | 1.60 | 1.56 | |
Current Ratio |
2.57 | 2.50 | 2.00 | 1.99 | |
Net Debt/EBITDA |
68.54 | 47.10 | 45.86 | 30.04 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.81 | 0.85 | 0.90 | 0.97 | |
Operating CF/Net income |
(0.26) | 1.63 | 5.18 | 3.02 | |
Capex/Depreciation |
(1.54) | (0.23) | (10.45) | (14.13) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
38.05% | 39.13% | 38.28% | 42.79% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.37% | 0.30% | 0.00% | 0.00% | |
Graham Net Nets |
0.42 | 0.54 | 0.39 | 0.64 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(0.30%) | (2.55%) | (3.72%) | (8.77%) | |
Free Cash Flow Yield |
(9.79%) | (17.07%) | (26.31%) | (23.02%) | |
Revenue per Share |
0.82 | 0.85 | 0.91 | 0.89 | |
Operating CF per Share |
0.01 | (0.08) | (0.08) | (0.16) | |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.04) | |
Free Cash Flow per Share |
0.01 | (0.08) | (0.09) | (0.20) | |
Cash per Share |
2.78 | 2.51 | 2.09 | 2.17 | |
Shareholders Equity per Share |
2.27 | 2.04 | 1.62 | 1.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.27 | 2.04 | 1.62 | 1.77 | |
Free Cash Flow |
0.07 | (0.96) | (0.91) | (1.69) | |
Working Capital |
23.13 | 20.51 | 13.29 | 11.77 | |
Capital Expenditures |
(0.04) | 0.00 | (0.11) | (0.32) | |
Net Current Asset Value |
21.79 | 19.20 | 11.05 | 9.70 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 1.53 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.04 | |
Net Profit Margin |
(4.55%) | (6.03%) | (1.67%) | (5.93%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
0.78 | 0.73 | 1.14 | 0.96 | |
Average Inventory |
2.92 | 2.66 | 2.39 | 2.41 | |
Average Assets |
50.27 | 46.89 | 42.56 | 37.19 | |
Average Common Equity |
30.73 | 28.15 | 23.67 | 22.03 |
Columns are period end dates